×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Principal Investigator  
Principal Investigator's Name: Yoonjeong Cha
Institution: Immuneering
Department: Genomics
Country:
Proposed Analysis: To further the biological understanding of Alzheimer’s disease (AD) and identify novel biological targets, Immuneering aims to leverage the wealth of newly available clinical and other genomic data. To accomplish this, we plan to utilize PET and MR imaging data along with clinical and genetics data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Study. The ADNI study provides an extensive resource for identifying biological mechanisms underlying AD pathology. We hope to grow the community understanding of AD by publishing our findings in peer-reviewed articles and aspire to present our observations at scientific AD relevant conferences. Any publication or presentation will include proper citations to the ADNI repositories and their authors, and Immuneering will follow proper protocol as outlined by the ADNI.
Additional Investigators  
Investigator's Name: Jermaine Ross
Proposed Analysis: To further the biological understanding of Alzheimer’s disease (AD) and identify novel biological targets, Immuneering aims to leverage the wealth of newly available clinical and other genomic data. To accomplish this, we plan to utilize PET and MR imaging data along with clinical and genetics data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Study. The ADNI study provides an extensive resource for identifying biological mechanisms underlying AD pathology. We hope to grow the community understanding of AD by publishing our findings in peer-reviewed articles and aspire to present our observations at scientific AD relevant conferences. Any publication or presentation will include proper citations to the ADNI repositories and their authors, and Immuneering will follow proper protocol as outlined by the ADNI.
Investigator's Name: Rebecca Kusko
Proposed Analysis: To further the biological understanding of Alzheimer’s disease (AD) and identify novel biological targets, Immuneering aims to leverage the wealth of newly available clinical and other genomic data. To accomplish this, we plan to utilize PET and MR imaging data along with clinical and genetics data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Study. The ADNI study provides an extensive resource for identifying biological mechanisms underlying AD pathology. We hope to grow the community understanding of AD by publishing our findings in peer-reviewed articles and aspire to present our observations at scientific AD relevant conferences. Any publication or presentation will include proper citations to the ADNI repositories and their authors, and Immuneering will follow proper protocol as outlined by the ADNI.
Investigator's Name: Rajaraman Krishnan
Proposed Analysis: To further the biological understanding of Alzheimer’s disease (AD) and identify novel biological targets, Immuneering aims to leverage the wealth of newly available clinical and other genomic data. To accomplish this, we plan to utilize Positron Emission Tomography (PET) and Magentic Resonance (MR) imaging data along with clinical and genetics data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Study. We hope to use the ADNI study to aid in the research of identifying biological mechanisms underlying AD pathology. We hope to grow the community understanding of AD by publishing our findings in peer-reviewed articles and aspire to present our observations at scientific AD relevant conferences. Any publication or presentation will include proper citations to the ADNI repositories and their authors, and Immuneering will follow proper protocol as outlined by the ADNI.